Suchergebnisse - "Jansson, Patric J"

PubPharm (16)

1

The mechanistic role of chemically diverse metal ions in the induction of autophagy

enthalten in: Pharmacological research | 2017

von Sahni, S. | Bae, D. | Jansson, P. | +1

2

Structure-Activity Relationships of Di-2-pyridylketone, 2-Benzoylpyridine, and 2-Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance

enthalten in: Journal of medicinal chemistry | 2016

von Stacy, A. | Palanimuthu, D. | Bernhardt, P. | +3

3

Copper and conquer : copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics

enthalten in: Metallomics : integrated biometal science | 2016

von Park, K. | Fouani, L. | Jansson, P. | +9

4

Redox cycling metals : Pedaling their roles in metabolism and their use in the development of novel therapeutics

enthalten in: Biochimica et biophysica acta | 2016

von Kalinowski, D. | Stefani, C. | Toyokuni, S. | +14

5

Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization

enthalten in: Journal of inorganic biochemistry | 2015

von Stefani, C. | Al-Eisawi, Z. | Jansson, P. | +2

6

The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms : persistent induction of autophagosome synthesis and impairment of lysosomal integrity

enthalten in: The Journal of biological chemistry | 2014

von Gutierrez, E. | Richardson, D. | Jansson, P.

7

The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells

enthalten in: The Journal of biological chemistry | 2014

von Sahni, S. | Bae, D. | Lane, D. | +4

8

The redox-active, anti-cancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism

enthalten in: Redox report : communications in free radical research | 2013

von Kalinowski, D. | Jansson, P. | Kovacevic, Z. | +1

CommentOn: FASEB J. 2013 Feb;27(2):782-92. - PMID 23134680

9

The iron chelator, deferasirox, as a novel strategy for cancer treatment : oral activity against human lung tumor xenografts and molecular mechanism of action

enthalten in: Molecular pharmacology | 2013

von Lui, G. | Obeidy, P. | Ford, S. | +7

10

Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo

enthalten in: Journal of medicinal chemistry | 2012

von Lovejoy, D. | Sharp, D. | Seebacher, N. | +9